Cite
Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells
MLA
Futoon Abedrabbu Al-Rawashde, et al. “Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ MTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.” Pharmaceuticals, vol. 15, no. 9, Sept. 2022, p. 1123. EBSCOhost, https://doi.org/10.3390/ph15091123.
APA
Futoon Abedrabbu Al-Rawashde, Abdullah Saleh Al-wajeeh, Mansoureh Nazari Vishkaei, Hanan Kamel M. Saad, Muhammad Farid Johan, Wan Rohani Wan Taib, Imilia Ismail, & Hamid Ali Nagi Al-Jamal. (2022). Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells. Pharmaceuticals, 15(9), 1123. https://doi.org/10.3390/ph15091123
Chicago
Futoon Abedrabbu Al-Rawashde, Abdullah Saleh Al-wajeeh, Mansoureh Nazari Vishkaei, Hanan Kamel M. Saad, Muhammad Farid Johan, Wan Rohani Wan Taib, Imilia Ismail, and Hamid Ali Nagi Al-Jamal. 2022. “Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ MTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.” Pharmaceuticals 15 (9): 1123. doi:10.3390/ph15091123.